Epic Research Update : Glenmark Pharmaceuticals

Glenmark Pharmaceuticals through its Swiss Subsidiary has received $4 million as research fee payment from Forest Laboratories on collaboration for the development of novel mPGES-1 inhibitors to treat chronic inflammatory conditions, including pain.

For more information ✆ - 0731-6642300 or Visit http://ift.tt/1doLhaI

Posted in: Indian Market Tips